Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/16381
Наслов: Peritoneal Dialysis-Related Peritonitis: Rate, Clinical Outcomes and Patient Survival
Authors: Dzekova Vidimliski, Pavlina 
Nikolov, Igor 
Gjorgjievski, Nikola 
Selim Gjulsen 
Trajcheska, Lada 
Stojanoska, Ana 
Rambabova Bushljetik, Irena 
Simeonov, Risto
Stojkovski, Ljupco
Issue Date: 1-дек-2021
Publisher: Macedonian Academy of Sciences and Arts/Walter de Gruyter GmbH
Journal: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 
Abstract: Peritoneal dialysis-related peritonitis remains the major complication and primary challenge to the long-term success of peritoneal dialysis (PD). The study aimed to analyze the peritonitis rate, the cause, the outcomes, and the association of peritonitis with the survival of patients on peritoneal dialysis. Patient data were collected retrospectively from medical charts. A total of 96 patients received peritoneal dialysis in the PD center from 1 January 1999 to 31 December 2018. Episodes of peritonitis (n=159) were registered in 54 (56.3%) patients. The study population was divided into two groups, a group of patients (n=54) who experienced peritonitis and a group of patients free of peritonitis (n=42). The peritonitis rate was 0.47 episodes per patient year. The majority of causative microorganisms were gram-positive bacteria (53.5%). Outcomes of the episodes of peritonitis were resolved infection in 84.9% of episodes, catheter removal in 11.3% of episodes, and death in 3.8% of the episodes of peritonitis. A Kaplan–Meier analysis and log-rank test revealed that the group with peritonitis tended to survive significantly longer than the peritonitis-free group. A 67% reduction rate in the risk of patient mortality was observed for the peritonitis group compared with the peritonitis-free group (hazard ratio: 0.33, 95% CI 0.19-0.57, P=0.000). The prevention and management of PD-related infections, resulted in their worldwide reduction, supporting the use of PD as a first-line dialysis modality.</jats:p>
URI: http://hdl.handle.net/20.500.12188/16381
DOI: 10.2478/prilozi-2021-0034
Appears in Collections:Faculty of Medicine: Journal Articles

Прикажи целосна запис

Page view(s)

47
checked on 13.5.2024

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.